by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
Boredom in Trading: Why Doing Nothing Is One of the Hardest (and Most Profitable) Skills One of the least discussed — yet most destructive — forces in active trading is boredom in trading psychology. Not fear. Not greed. Boredom. Sitting in front of a screen, watching...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
Nvidia’s “Tremendous” AI Demand Message: What Traders Should Watch as Vera Rubin Heads Toward Launch Nvidia didn’t need an earnings surprise to move the conversation this week. At CES, the company reinforced a simple narrative: Demand for AI and accelerated computing...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
Plan the Trade. Trade the Plan. Why Discipline Is the Real Edge (ATI Case Study) One of the biggest advantages in markets isn’t a new indicator, a faster feed, or a better opinion. It’s trading discipline and execution—the ability to follow your plan to the letter...
by ADRIAN MANZ | Jan 6, 2026 | The Doctor's Dose
How to Stop FOMO in Trading: When a “Right Trade” Becomes a Losing Trade Sometimes the trade idea is right… and the trader still loses. The culprit is often simple: entry discipline gets replaced by urgency. How to Stop FOMO in Trading Starts With One Truth: The Entry...
by ADRIAN MANZ | Jan 4, 2026 | The Doctor's Dose
The Impact of Venezuela Sanctions on Traders: What Markets May React to This Week Geopolitical headlines don’t need to trigger a crisis to matter. Often, the real impact of Venezuela sanctions on traders comes from how uncertainty alters expectations, volatility, and...
by ADRIAN MANZ | Jan 4, 2026 | The Doctor's Dose
Trader Psychology for the Week Ahead: A Weekend Reset for Clarity, Energy, and Expectation Control The best trading weeks don’t start on Monday — they start with how you recover on the weekend. Trader psychology for the week ahead is about arriving at the opening bell...
by ADRIAN MANZ | Jan 2, 2026 | The Doctor's Dose
Tesla Loses Its Crown: What BYD’s Rise Means for TSLA Traders Focus keyphrase: Tesla sales decline trading impact Tesla is no longer the top global EV seller. After posting a second consecutive annual decline in deliveries, Tesla has been surpassed in EV sales by...
by ADRIAN MANZ | Dec 31, 2025 | The Doctor's Dose
China’s AI Advances Are Back — and Traders Should Care Just as U.S. markets were waiting for the next leg higher in AI leadership stocks, China has reintroduced a familiar wildcard. Reports of a photon-based computing chip for AI training and inference—dubbed...
by ADRIAN MANZ | Dec 30, 2025 | The Doctor's Dose
The Hidden Perils of Pre- and Post-Holiday Trading Why the Open Is the Only Liquidity That Matters Holiday trading weeks lure traders into a dangerous illusion. The screens are on. The market is open. Prices are moving. So it feels like opportunity. But in reality,...
by ADRIAN MANZ | Dec 30, 2025 | The Doctor's Dose
AI Chip Boom Enters Its Most Important Phase: Opportunity, Competition, and Risk The global semiconductor industry just posted its largest year on record. Driven by explosive growth in artificial intelligence, the world’s largest chipmakers generated more than $400...
